4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-068453
General Counsel and Secretary gave up 6,303 shares (to pay taxes)
- General Counsel and Secretary acquired 13,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2021-12-03 | Option exercise | +13,333 | 49,845 | D: show line 1 in the form | ||
| KASINGER JAMES R. General Counsel and Secretary | 2021-12-06 | Shares withheld for taxes | −6,303 | $69.17 | $435,979 | 43,542 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2021-12-03 | Option exercise · Restricted Stock Units | +13,333 | 6,667 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…